99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam

Product Details
Customization: Available
Powder: Yes
Certification: ISO 9001, FDA
Still deciding? Get samples of US$ 1/kg
Request Sample
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Experienced Team
The supplier has 12 foreign trading staff(s) and 10 staff(s) with over 6 years of overseas trading experience
In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
to see all verified strength labels (12)
  • 99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam
  • 99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam
  • 99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam
  • 99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam
  • 99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam
  • 99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam
Find Similar Products
  • Overview
  • Description
  • COA
  • Application & Funtion
  • Company
Overview

Basic Info.

Model NO.
SENTIAN-Lornoxicam
Use
Healthy
MOQ
10g
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Trademark
SENTIAN
Origin
China
Production Capacity
5000 Kg Per Month

Product Description

.

 

Description

 

product name Lornoxicam
CAS NO. 70374-39-9
Specification 99%
Appearance yellow powder
packing 1kg/bag,25kgs/drum
MOQ 1KG

Lornoxicam is the chloride of tenoxicam. Its effects are similar to those of piroxicam, with analgesic, anti-inflammatory and antipyretic effects. It can selectively inhibit COX-2, and its intensity is slightly weaker than that of piroxicam. It activates the opioid neuropeptide system and exerts a central analgesic effect. This product has a weak antipyretic effect, and the required dose is 10 times the anti-inflammatory dose. Oral absorption is slow, and the peak blood concentration is reached in 24 hours. Food may reduce its absorption rate by 20% and delay its absorption rate. It is distributed throughout the body and also in the synovial fluid.

Lornoxicam can be used to treat chronic low back pain, acute sciatica, postoperative pain, acute mild to moderate pain, and joint pain and inflammation caused by osteoarthritis and rheumatoid arthritis.

Usage and Dosage:
Oral dosage form, 8-16 mg per day (8 mg per tablet, 1-2 tablets) when in pain, taken in 2-3 times. Intramuscular or intravenous injection: For short-term treatment of acute moderate pain after surgery, the recommended dose is 8 mg and the maximum daily dose is 16 mg. Some patients can add 8 mg within the first 24 hours, and deep intramuscular injection should be performed. Please follow the doctor's advice for details. Note that the intramuscular injection time of lornoxicam is at least 5 seconds and the intravenous injection time is at least 15 seconds. Patients with mild to moderate renal impairment and moderate liver impairment should consider reducing the dosage. The recommended maximum oral dose is 12 mg, taken in 2-3 times. Please follow the doctor's advice for details. Lornoxicam should not be taken for a long time or during meals.
 

COA

 

Item Specification Test result
Appearance ywllow powder Conforms
Assay 99% Conforms
Heavy metal ≤10ppm Conforms
Lead ≤2.0ppm Conforms
As ≤2.0ppm Conforms
Ca ≤1.0ppm Conforms
Me ≤0.1ppm Conforms
Total aerobic microbial count ≤1000CFU/g Conforms
Total moulds&yeast count ≤100CFU/g Conforms
Enterobacterial ≤10MPN/g Conforms
Salmonella N.D/25g Conforms
Escherichia coli N.D/10g Conforms
Staphylococcus aureus N.D/10g Conforms
Pseudomonas aeruginosa N.D/10g Conforms
Conclusion: Conform with specification.

 

Application & Funtion

Lornoxicam can be used for acute pain after gynecological and orthopedic surgery, acute sciatica or low back pain. It can also be used for chronic low back pain, arthritis, rheumatoid arthritis and ankylosing spondylitis.

It is contraindicated in patients with acute gastrointestinal bleeding or active ulcers, moderate to severe renal impairment, severe liver impairment, severe heart failure, and pregnant and lactating women. It is contraindicated for patients under 18 years of age.
It should be used with caution in the elderly, asthmatics, patients with impaired liver and kidney function, and patients with a history of gastrointestinal bleeding or duodenal ulcers, and patients with coagulation disorders.

Company

99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam99% Lornoxicam Powder CAS 70374-39-9 Anti-Inflammatory Lornoxicam

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier